Stock Comparison
ARGX vs INSM
argenx NV ADR and Insmed Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$22.41B
P/E (TTM)
39.4
—
Forward P/E
34.0
16.4
Price/Sales
11.7
27.3
Price/Book
7.5
31.8
EV/EBITDA
33.9
-6.1
Dividend Yield
—
—
Profitability
Net Margin
31.40%
-144.40%
Operating Margin
30.00%
-65.50%
Return on Equity
20.20%
-294.50%
Return on Assets
8.86%
-31.10%
Growth (YoY)
Revenue Growth
62.60%
229.60%
Earnings Growth
114.00%
0.00%
Price & Risk
Beta
-0.0
0.8
52-Week High
$934.62
$212.75
52-Week Low
$510.06
$90.39
Analyst Target
$1,041.14
$197.05
Compare ARGX and INSM your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.